weight-loss drugs: Demand for weight-loss drugs fuels global rise in counterfeits

The increasing demand for weight-loss drugs such as Novo Nordisk's Ozempic has led to a rise in counterfeit versions of these medications. Law enforcement agencies, anti-counterfeiting organizations, and public health officials are collaborating to combat this issue. The popularity of weight-loss drugs has made them a target for criminal organizations. Novo Nordisk and Eli Lilly, the manufacturers of these drugs, are working with various agencies to identify and deter counterfeit products.

Related Keywords

Germany ,Egypt ,World Health Organization ,Al Qahirah ,Russia ,United States ,United Kingdom ,Ireland ,Britain ,America ,Jim Mancuso ,Yoav Keren ,Eli Lilly ,Novo Ozempic ,Novo Nordisk Ozempic ,Lilly Mounjaro ,Regulatory Agency ,Novo Nordisk ,U Pharmaceutical Security Institute ,Drug Administration ,A World Health Organization ,Reuters ,Ireland Health Products Regulatory Authority ,Pharmaceutical Security Institute ,Homeland Security ,Intellectual Property Rights Coordination ,North America ,Middle East ,Health Products Regulatory Authority ,Weight Loss Drugs ,Health Care ,Ozempic ,Wegovy ,